Colitis ulcerosa: vizsgálatok itt: Lettország
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleAn Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
- Where
- Liepaja, Riga
- Életkor
- 18 év and over
- People
- 587 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2023-507853-13-00 · EU 2023-507853-13-00 - 2. fázisTaking peopleLY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Where
- Riga
- Életkor
- 18 év to 80 év
- People
- 1431 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07415044 - 2. fázisTaking peopleA study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
- Where
- Riga
- Életkor
- 18 év and over
- People
- 104 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-524404-29-00 · EU 2025-524404-29-00 - 2. fázisTaking peopleA Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Liepāja, Riga
- Életkor
- 18 év to 75 év
- People
- 204 worldwide
- Run by
- Palisade Bio
See details and how to joinNCT07845487